Kahn RS - Search Results

1

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.

Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, Eijkemans MJC, Fleischhacker WW, Kapur S, Sommer IE; OPTiMiSE study group. Kahn RS, et al. Lancet Psychiatry. 2018 Oct;5(10):797-807. doi: 10.1016/S2215-0366(18)30252-9. Epub 2018 Aug 13. Lancet Psychiatry. 2018. PMID: 30115598 Clinical Trial.

2

Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.

Kahn RS, Siever LJ, Gabriel S, Amin F, Stern RG, DuMont K, Apter S, Davidson M. Kahn RS, et al. Psychiatry Res. 1992 Jul;43(1):1-12. doi: 10.1016/0165-1781(92)90136-q. Psychiatry Res. 1992. PMID: 1332094 Clinical Trial.

3

Effect of m-chlorophenylpiperazine on plasma homovanillic acid concentrations in healthy subjects.

Kahn RS, Knott P, Gabriel S, DuMont K, Mastroianni L, Davidson M. Kahn RS, et al. Biol Psychiatry. 1992 Dec 1;32(11):1055-61. doi: 10.1016/0006-3223(92)90068-b. Biol Psychiatry. 1992. PMID: 1467386 Clinical Trial.

4

Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.

Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL. Davidson M, et al. Among authors: kahn rs. Arch Gen Psychiatry. 1991 Jan;48(1):73-6. doi: 10.1001/archpsyc.1991.01810250075011. Arch Gen Psychiatry. 1991. PMID: 1670618

5

Dopamine in schizophrenia: a review and reconceptualization.

Davis KL, Kahn RS, Ko G, Davidson M. Davis KL, et al. Among authors: kahn rs. Am J Psychiatry. 1991 Nov;148(11):1474-86. doi: 10.1176/ajp.148.11.1474. Am J Psychiatry. 1991. PMID: 1681750 Review.

6

Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients.

Harvey PD, Putnam KM, Davidson M, Kahn RS, Powchik P, McQueeney R, Keefe RS, Davis KL. Harvey PD, et al. Among authors: kahn rs. Psychiatry Res. 1991 Sep;38(3):285-92. doi: 10.1016/0165-1781(91)90018-k. Psychiatry Res. 1991. PMID: 1684442

7

Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.

Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL. Davidson M, et al. Among authors: kahn rs. Arch Gen Psychiatry. 1991 Oct;48(10):910-3. doi: 10.1001/archpsyc.1991.01810340042005. Arch Gen Psychiatry. 1991. PMID: 1929760

8

Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.

Kahn RS, Davidson M, Knott P, Stern RG, Apter S, Davis KL. Kahn RS, et al. Arch Gen Psychiatry. 1993 Aug;50(8):599-605. doi: 10.1001/archpsyc.1993.01820200009001. Arch Gen Psychiatry. 1993. PMID: 7688208

9

Serotonin, dopamine and their interactions in schizophrenia.

Kahn RS, Davidson M. Kahn RS, et al. Psychopharmacology (Berl). 1993;112(1 Suppl):S1-4. doi: 10.1007/BF02245002. Psychopharmacology (Berl). 1993. PMID: 7831437 Review. No abstract available.

10

Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine.

Kahn RS, Siever L, Davidson M, Greenwald C, Moore C. Kahn RS, et al. Psychopharmacology (Berl). 1993;112(1 Suppl):S90-4. doi: 10.1007/BF02245012. Psychopharmacology (Berl). 1993. PMID: 7831445 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,126 results

Search Page